Biopharmaceutical company GW Pharmaceuticals PLC nets $273.1mm in follow-on offering
GW Pharmaceuticals PLC netted $273.1mm in a follow-on public offering of 2.8mm American Depository Shares (ADSs; each ADS equals 12 ordinary shares) and the full exercise of the 420k over-allotment option at $90 per ADS. The company is developing a product portfolio of cannabinoid medicines for a wide range of indications.
Drug Discovery Tools
- Natural Products
- Molecular Diversity
- Drug Discovery Tools
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.